Evidence map›Paper›PMID 34681686›Full record

ArticleInternational journal of molecular sciences2021

Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity against

Da-Gyum Lee, Yoo-Hyun Hwang, Eun-Jin Park, Jung-Hyun Kim, Sung-Weon Ryoo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Integrative transcriptome-based drug repurposing in tuberculosis.bioRxiv : the preprint server for biology · 2025
    Article
  2. Review
  3. A laboratory perspective onFrontiers in microbiology · 2024
    Review
  4. 10-DEBC Hydrochloride as a Promising New Agent against Infection ofInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Da-Gyum LeeCenter for Clinical Research, Masan National Tuberculosis Hospital, Korea Centers for Disease Control and Prevention, Changwon 51755, Korea.
Yoo-Hyun HwangCenter for Clinical Research, Masan National Tuberculosis Hospital, Korea Centers for Disease Control and Prevention, Changwon 51755, Korea.
Eun-Jin ParkCenter for Clinical Research, Masan National Tuberculosis Hospital, Korea Centers for Disease Control and Prevention, Changwon 51755, Korea.ORCID 0000-0002-1014-4820
Jung-Hyun KimDivision of Intractable Diseases, Center for Biomedical Sciences, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju 28159, Korea.ORCID 0000-0002-9496-9474
Sung-Weon RyooCenter for Clinical Research, Masan National Tuberculosis Hospital, Korea Centers for Disease Control and Prevention, Changwon 51755, Korea.ORCID 0000-0002-5085-0068
Masan National Tuberculosis Hospital · KRChungnam National University · KRKorea National Institute of Health · KR

Funding

Korea Health Technology R&D Project through the Korea Health Industry Development Institute HI20C0478
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MacrophagesAnti-Bacterial AgentsClomipheneDrug RepositioningHumansMycobacterium abscessusMycobacterium Infections, NontuberculousTHP-1 CellsAnti-Bacterial AgentsClomipheneclomiphene citratedrug repurposingdrug resistanceMycobacterium abscessusnon-tuberculosis mycobacteria

Identifiers

PMID34681686
PMCPMC8537717
OpenAlexW3206693056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.